Results 271 to 280 of about 328,521 (340)

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation

open access: yesEuropean Journal of Clinical Investigation, Volume 55, Issue 8, August 2025.
This consensus highlights critical research gaps in obesity epidemiology, phenotypic heterogeneity and clinical management, calling for advanced methodologies, collaborative strategies and innovative policies to mitigate the global obesity epidemic and its socio‐economic impacts.
Federico Carbone   +28 more
wiley   +1 more source

Correction: Sex differences in problematic pornography use among adolescents: a network analysis. [PDF]

open access: yesBMC Psychol
Villena-Moya A   +10 more
europepmc   +1 more source

Unraveling Audiovisual Perception Across Space and Time: A Neuroinspired Computational Architecture

open access: yesEuropean Journal of Neuroscience, Volume 62, Issue 3, August 2025.
Fitted on auditory localization and reaction time task data, our neurocomputational model aims to elucidate the mechanisms underlying multisensory perception in the entire spatiotemporal domain, predicting how spatial and temporal factors interact to modulate sensory perception.
Cristiano Cuppini   +3 more
wiley   +1 more source

Hogares y caseríos en la Navarra cantábrica en el siglo XIX. Un enfoque microanalítico

open access: diamond, 2003
Pilar Erdozáin Azpilicueta   +2 more
openalex   +2 more sources

Mediterranean diet and obesity polygenic risk interaction on adiposity in European children: The IDEFICS/I.Family Study

open access: yesPediatric Obesity, Volume 20, Issue 8, August 2025.
Summary Background and Objectives To examine whether changes in the Mediterranean Diet (MD) or any of its MD food groups modulate the genetic susceptibility to obesity in European youth, both in cross‐sectional and longitudinal analyses. Methods For cross‐sectional analysis, 1982 participants at baseline, 1649 in follow‐up 1 (FU1) and 1907 in follow‐up
Miguel Seral‐Cortes   +20 more
wiley   +1 more source

Talquetamab improves patient‐reported symptoms and health‐related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL‐1 study

open access: yesCancer, Volume 131, Issue 14, 15 July 2025.
Abstract Background Talquetamab is the first approved G protein–coupled receptor family C group 5 member D–targeting bispecific antibody for the treatment of triple‐class exposed relapsed/refractory multiple myeloma (RRMM) on the basis of results from the phase 1/2 MonumenTAL‐1 study (ClinicalTrials.gov identifiers NCT03399799 and NCT04634552).
Carolina Schinke   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy